Plague

9 registered clinical trials studyying Plague — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Testing of a New Rapid Antigen Test for Plague in Ituri, Democratic Republic of the Congo. NCT07174648	Institute of Tropical Medicine, Belgium	—
Completed	Trial of the Immunogenicity, Safety, and Tolerability of rF1V Vaccine With CpG 1018® Adjuvant Compared With rF NCT05506969	Dynavax Technologies Corporation	Phase 2
Unknown	Yersinia Pestis Lateral Flow Immunoassay for Blood Samples NCT04688996	Brimrose Technology Corporation	—
Unknown	Immunogenicity and Safety of Subunit Vaccine of Plague Vaccine With Two Immunization Regimens NCT05330624	Jiangsu Province Centers for Disease Control and Prevention	Phase 2
Completed	Immunogenicity and Safety of Subunit Plague Vaccine NCT02596308	Jiangsu Province Centers for Disease Control and Prevention	Phase 2
Completed	Dose Escalation Trial of a Plague Vaccine, Flagellin/F1/V, in Healthy Adult Volunteers NCT01381744	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 1
Completed	A Clinical Trial to Evaluate the Safety and Efficacy of Ciprofloxacin in the Treatment of Plague in Humans NCT01243437	Centers for Disease Control and Prevention	Phase 2
Completed	One Year Study to Evaluate Three Different Adjuvanted Doses of the Recombinant Plague Vaccine (rF1 and rV Anti NCT00246467	PharmAthene UK Limited	Phase 1
Completed	Treatment and Diagnosis of Plague NCT00128466	Centers for Disease Control and Prevention	Phase 2 / Phase 3